ETAP-Lab is seeking for a laboratory technician for its STROK@LLIANCE in vivo lab in Caen (14000).
  • Job: laboratory technician
  • Type of contract: temporary position (CDD)
  • Duration: 6 months (potentially extended)
Under the supervision of the project manager you will contribute to the set up and performing of in vivo and in vitro experimentations and you will ensure proper lab functioning; both in compliance with the Good Laboratory Practice. You have now the opportunity to join a young and dynamic team looking for challenge in a high level scientific and technological environment. Dowload the full post description.
ETAP-Lab recherche un technicien de laboratoire pour son centre d’expérimentation in vivo de Caen (14000): STROK@LLIANCE.
  • Poste: Technicien de laboratoire (Bac+2/+3)
  • Type de contrat: CDD
  • Durée: 6 mois
Sous l’autorité du responsable de projet vous aurez pour objectif de contribuer à la préparation et à la réalisation des expérimentations in vivo et in vitro ainsi qu’au bon fonctionnement du laboratoire tout en respectant les normes qualité. Vous avez l’opportunité de rejoindre une équipe jeune et dynamique, avide de challenge, dans un environnement scientifique et technologique. Téléchargez la description complète du poste.

 Meet us at ESOC 2017

Dr. Nicolas VIOLLE will attend to the 3rd European Stroke Organization Conference ​ (ESOC) from 16-18 May, 2017 (Prague).

ESOC is one of the most exiting conference this year about clinical trials and developments in stroke management, treatment and prevention.
It will be the occasion for us to meet leaders from pharmaceutical industry to present STROM@LLIANCE, the new service 100% dedicated to preclinical stroke research.

Contact us from now to schedule a meeting.

May 10th, 2017 – 11:00 AM – 4:30 PM

28 Rue Saint-Dominique, 75007 Paris

Launch of STROK@LLIANCE, the new preclinical platform resulting from the alliance of the public Experimental Stroke Research Platform (ESRP) and the well-established CRO ETAP-Lab.

For half a day, neurologists, neuroradiologists, neurosurgeons, researchers, specialists in preclinical and clinical trials, will give you an overview of stroke etiology, current acute management practices and animal modeling. Next, they will discuss with you during a debate: “The transition from preclinical drug to clinical drug for stroke: What are the essential information for clinicians about pharmacology issues?”

Final Program May 10th